PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 19, 2026Experimental Hematology and Oncology0 citationsOpen Access

Single-cell profiling reveals FAM117A as a key regulator linking macrophage–epithelial crosstalk with the progression of lung adenocarcinoma

CWChao WuZRZhipeng RenGCGang Che

Key Points

  • The research aims to investigate the role of FAM117A in macrophage-epithelial interactions and its impact on lung adenocarcinoma progression.
  • Utilized single-cell RNA sequencing to identify communication networks in the tumor microenvironment.
  • Conducted immunohistochemical studies to assess FAM117A expression in lung adenocarcinoma tissues.
  • Performed transcriptomic modeling to analyze the regulatory role of FAM117A.
  • Examined the effects of FAM117A treatment and CDK4/6 inhibition on tumor growth in vitro and in vivo.
  • Identified a macrophage and basal epithelial communication module enriched in invasive lung adenocarcinoma regions.
  • Observed decreased FAM117A expression correlating with higher macrophage density and poor prognosis.
  • Loss of FAM117A was linked to prolonged cell cycle phases and increased cell proliferation.
  • Treatment targeting FAM117A reduced tumor growth in experimented conditions.

Abstract

The tumor microenvironment (TME) has a profound influence on the progression of lung adenocarcinoma (LUAD) and its response to therapy. We identified a tumor-promoting communication network based on single-cell RNA sequencing. This shows an SPP1 + macrophage and basal epithelial cell communication module (CIM) that is enriched in invasive portions of tumors, and spatially associated with decreased cytotoxic T cell activity and poor prognosis. Transcriptomic modeling identified FAM117A as a major suppressor of the CIM network. FAM117A is a DYRK1A-interacting cell-cycle regulator. Loss of FAM117A resulted in longer G1/S transition time, increased cell proliferation, and an enhanced macrophage-epithelial feedback loop. Immunohistochemical studies showed decreased FAM117A expression in LUAD tissues, which correlated with SPP1 + macrophage density and poor outcome. Treatment with FAM117A or pharmacological inhibition of CDK4/6 reduced the in vitro and in vivo tumor growth. Thus, FAM117A links intrinsic cell cycle regulation with the extrinsic immune microenvironment, providing a rationale for combined therapies that address macrophage-tumor and cell cycle regulatory events in LUAD.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wu et al. (2026) studied this question.

synapsesocial.com/papers/6996a768ecb39a600b3ed022https://doi.org/10.1186/s40164-026-00745-9
Ask AI
Helpful
Bookmark
Share
View Full Paper